iCanWork: A Randomized Controlled Trial
iCanWork
Effects of the iCanWork Intervention to Improve Cancer Survivors' Experience With Return to Work: A Randomized Controlled Trial (RCT)
1 other identifier
interventional
270
1 country
1
Brief Summary
The aim of this study is to evaluate the effectiveness of the iCanWork intervention in assisting cancer survivors (CS) to return to work (RTW) and its impact on their health-related quality of life (QoL), health service utilization, RTW readiness, time to RTW, and work capacity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 15, 2022
CompletedFirst Posted
Study publicly available on registry
September 21, 2022
CompletedStudy Start
First participant enrolled
April 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
ExpectedSeptember 26, 2022
September 1, 2022
2.4 years
September 15, 2022
September 22, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline return to work status in the course of the 24-month study
binary variable (Yes/No)
baseline, 6 months, 12 months, 18 months, 24 months
Secondary Outcomes (3)
Change from baseline health related quality of life in the course of the 24-month study
baseline, 6 months, 12 months, 18 months, 24 months
Change from baseline readiness to return to work in the course of the 24-month study
baseline, 6 months, 12 months, 18 months, 24 months
Change from baseline work capacity in the course of the 24-month study
baseline, 6 months, 12 months, 18 months, 24 months
Study Arms (2)
iCanWork Intervention
EXPERIMENTALiCanWork includes 6 1-hour sessions with a VRC and 1 to 4 1-hour sessions with an OT. In the positive event that a participant has returned to work during the study, three of the six VRC sessions are reserved to support the participants in their transition to the workplace.
Control
NO INTERVENTIONParticipants randomized to the control group will receive their usual care and will be referred to the Cancer Work website for educational resources related to RTW. If they contact the team with RTW-related questions, they will be referred to their care teams.
Interventions
Participants will receive RTW support from the VRC and OT.
Eligibility Criteria
You may qualify if:
- diagnosed with cancer (all types) treated with curative intent and of working age (between 18 and 65 at the time of diagnosis)
- gainfully employed at the time of diagnosis (full or part-time, including students)
- still on sick leave, including long-term disability leave, but for less than 2 years
- has not started to return to work, since stopping due to cancer
- can read and understand English or French
- reside in Canada.
You may not qualify if:
- \- If the cancer survivor's physicians consider returning to work unwise, such as due to a metastatic cancer diagnosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
McGill University
Montreal, Quebec, H3A 0G4, Canada
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 15, 2022
First Posted
September 21, 2022
Study Start
April 1, 2023
Primary Completion
September 1, 2025
Study Completion (Estimated)
September 1, 2026
Last Updated
September 26, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
Study Protocol will be published with an open access peer-reviewed journal